Close Menu

NEW YORK ─ Siemens Healthineers said Wednesday it has received the CE mark for its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay, allowing for its use as a clinical diagnostic test in Europe.

The firm also registered the test with the Luxembourg Ministry of Health and said it plans to ship more than 1.3 million tests per month worldwide as production capacity increases in May.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.